Submission declined on 28 August 2025 by Padgriffin (talk).
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
| Submission declined on 9 August 2025 by Gheus (talk). This draft's references do not show that the subject qualifies for a Wikipedia article. In summary, the draft needs multiple published sources that are: Declined by Gheus 21 days ago.
| |
| Submission declined on 22 July 2025 by Pythoncoder (talk). Your draft shows signs of having been generated by a large language model, such as ChatGPT. Their outputs usually have multiple issues that prevent them from meeting our guidelines on writing articles. These include: Declined by Pythoncoder 39 days ago.
| |
| Submission declined on 21 July 2025 by Tenshi Hinanawi (talk). Your draft shows signs of having been generated by a large language model, such as ChatGPT. Their outputs usually have multiple issues that prevent them from meeting our guidelines on writing articles. These include:
This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Declined by Tenshi Hinanawi 40 days ago. | |
| Submission declined on 16 June 2025 by GoldRomean (talk). This submission appears to read more like an advertisement than an entry in an encyclopedia. Encyclopedia articles need to be written from a neutral point of view, and should refer to a range of independent, reliable, published sources, not just to materials produced by the creator of the subject being discussed. This is important so that the article can meet Wikipedia's verifiability policy and the notability of the subject can be established. If you still feel that this subject is worthy of inclusion in Wikipedia, please rewrite your submission to comply with these policies. Your draft shows signs of having been generated by a large language model, such as ChatGPT. Their outputs usually have multiple issues that prevent them from meeting our guidelines on writing articles. These include: Declined by GoldRomean 2 months ago.
| |
Comment: See WP:CORPTRIV. Gheus (talk) 15:11, 9 August 2025 (UTC)
 | A major contributor to this article appears to have a close connection with its subject. |
| Company type | Private |
|---|---|
| Industry | Clinical trial software |
| Founded | 2012 |
| Founder | Derk Arts |
| Headquarters | Amsterdam; New York City , Netherlands; United States |
Castor is a Dutch software company that develops tools for electronic data capture (EDC) used in clinical trials and other clinical research.[1] The platform has been described in independent coverage as supporting eCRF design, randomisation in randomized controlled trials, ePRO/eCOA, eConsent, and features used in decentralized or hybrid studies.[1][2]
History
editCastor was founded in the Netherlands in 2012 by physician–researcher Derk Arts.[1] In 2020, Forbes reported the company’s US$12 million Series A funding in the context of COVID-19 research use cases.[3]
Software and services
editIndependent sources describe Castor as an EDC/CDMS with ePRO/eCOA and eConsent modules, and public APIs used to integrate real world data (RWD).[1][4] A 2022 CIO.com feature profiled Castor among Dutch health-technology firms building software for clinical research.[2]
Market analysis
editIndustry analyst Everest Group has included Castor in multiple PEAK Matrix® assessments. In 2024, Castor appeared among the “Major Contenders” in the Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix (20 vendors evaluated).[5][6] In 2023, Everest’s Decentralized Clinical Trial Platforms PEAK Matrix also listed Castor; public materials describe provider tiers and the evaluated vendors.[7][8]
Use in published research
editPeer-reviewed protocols and reports in multiple specialties name “Castor” in their methods:
- A randomized trial in Nature Medicine reports patient questionnaires delivered via Castor EDC in a heart-failure digital-consult study.[9]
- The HORIZON-IC multicentre RCT protocol in BMJ Open specifies randomization and questionnaires using Castor EDC.[10]
- The OPTIMA-BP protocol in Open Heart (BMJ) describes repeated surveys and data entry via Castor EDC.[11]
- A multinational registry protocol in Head & Face Medicine states the database was built on the “Castor Electronic Data Capture System (Castor EDC)”.[12]
During the COVID-19 pandemic, the World Health Organization acknowledged “Castor EDC” among organizations providing support to the Solidarity Trial Vaccines platform.[13]
Organization
editThe company operates in the Netherlands as Ciwit B.V. and in the United States as Castor Research, Inc..[14][15]
See also
editReferences
edit- ^ a b c d Hall, Christine (14 July 2021). "Castor, a clinical-trial process company, raises $45M to create more human-centered research". TechCrunch. Retrieved 11 August 2025.
- ^ a b Butcher, Melanie (26 June 2022). "4 exciting Dutch healthcare technology companies to watch". CIO.com. Retrieved 11 August 2025.
- ^ Jennings, Katie (19 August 2020). "This Big Data Startup Raised $12 Million To Speed Up Clinical Trials For Coronavirus Research". Forbes. Retrieved 11 August 2025.
- ^ van Linschoten, Reinier C. A.; Knijnenburg, Sebastiaan L.; West, Rachel L.; van Noord, Desirée (20 October 2023). "CastorEDC API: A Python package for managing real-world data in Castor Electronic Data Capture". Journal of Open Research Software. 11 (1): 12. doi:10.5334/jors.436.
- ^ Life Sciences Electronic Data Capture (EDC) Products – PEAK Matrix Assessment 2024 (Report). Everest Group. 3 September 2024. Retrieved 11 August 2025.
- ^ "Life Sciences EDC Products PEAK Matrix® 2024 – Focus on Oracle (licensed copy showing full vendor list)" (PDF). Everest Group. October 2024. Retrieved 11 August 2025.
- ^ "Decentralized Clinical Trial Platforms – PEAK Matrix® Assessment". Everest Group. 2023. Retrieved 11 August 2025.
- ^ "Decentralized Clinical Trial Platforms – PEAK Matrix® Assessment 2023 (licensed copy)" (PDF). Everest Group. 2023. Retrieved 11 August 2025.
- ^ Man, Jelle P.; Koole, Maarten A. C.; Meregalli, Paola G.; Handoko, M. Louis; Stienen, Susan; De Lange, Frederik J.; Winter, Michiel M.; Schijven, Marlies P.; Kok, Wouter E. M.; Kuipers, Dorianne I.; Van Der Harst, Pim; Asselbergs, Folkert W.; Zwinderman, Aeilko H.; Dijkgraaf, Marcel G. W.; Chamuleau, Steven A. J.; Schuuring, Mark J. (2024). "Digital consults in heart failure care: a randomized controlled trial" (PDF). Nature Medicine. 30 (10): 2907–2913. doi:10.1038/s41591-024-03238-6. PMC 11485254. PMID 39217271. Retrieved 11 August 2025.
- ^ Vlake, Johan Hendrik; Van Bommel, Jasper; Wils, Evert-Jan; Korevaar, Tim IM; Taccone, Fabio; Schut, Anna FC; Elderman, Jan H.; Labout, Joost AM; Raben, Adrienne MTJ; Dijkstra, Annemieke; Achterberg, Sefanja; Jurriens, Amber L.; Van Mol, Margo MC; Gommers, Diederik; Van Genderen, Michel E. (2022). "Effect of intensive care unit–specific virtual reality (ICU-VR) to improve psychological well-being in ICU survivors: study protocol for an international, multicentre, randomized controlled trial — the HORIZON-IC study". BMJ Open. 12 (9): e061876. doi:10.1136/bmjopen-2022-061876. PMC 9490570. PMID 36127077. Retrieved 11 August 2025.
{{cite journal}}: CS1 maint: article number as page number (link) - ^ McCallum, L.; Lip, S.; Rostron, M.; Hanna, R.; Bin Pg Md Salimin N; Nichol, S.; Padmanabhan, S. (2024). "OPTIMA-BP: protocol for a randomised parallel group study comparing a web-based education portal plus home blood pressure monitoring versus monitoring alone". Open Heart. 11 (1): e002535. doi:10.1136/openhrt-2023-002535. PMC 10910568. PMID 38429056.
{{cite journal}}: CS1 maint: article number as page number (link) - ^ Oechsle, A. L.; Wiechers, C.; Abadie, V.; Abel, F.; Breugem, C.; Poets, C. F. (2023). "International registry for Robin sequence: protocol and database design". Head & Face Medicine. 19 (1): 20. doi:10.1186/s13005-023-00364-3. PMC 10199645. PMID 37210548.
- ^ "WHO statement on Solidarity Trial Vaccines". World Health Organization. 26 October 2021. Retrieved 11 August 2025.
- ^ "Ciwit B.V." OpenCorporates. Retrieved 11 August 2025.
- ^ "Castor Research Inc. Company Profile". Dun & Bradstreet. Retrieved 11 August 2025.
- in-depth (not just brief mentions about the subject or routine announcements)
- reliable
- secondary
- strictly independent of the subject
Make sure you add references that meet all four of these criteria before resubmitting. Learn about mistakes to avoid when addressing this issue. If no additional references exist, the subject is not suitable for Wikipedia.